S-1: Digital Ally S-1: Resale of Convertible Note Shares

Digital Ally, Inc. filed an S-1 registration statement for the resale of 3,397,186 shares of common stock by a selling stockholder, stemming from a recent convertible note and warrant issuance.

Summary

• Registration of 2,777,777 shares of common stock underlying a Senior Secured Convertible Note and 619,409 shares underlying a Common Stock Purchase Warrant for resale by the Selling Stockholder, Yield Point NY LLC.
• The company will not receive any proceeds from the sale of these shares by the Selling Stockholder; however, it previously received net proceeds of approximately $610,000 from the initial sale of common shares under the Purchase Agreement, with $110,000 used for routine operational expenses.
• Digital Ally operates through three reportable segments: Video Solutions (digital video imaging, storage, safety products), Revenue Cycle Management (healthcare back-office services), and Entertainment (secondary ticketing via ticketsmarter.com and live event production, including Country Stampede).
• The company has a history of significant operating losses, including approximately $15.2 million for the year ended December 31, 2024, and an accumulated deficit of $137.5 million as of the same date.
• Management and the company's auditor have concluded that historical recurring losses and unstable cash flows raise substantial doubt about the company's ability to continue as a going concern.
• Two reverse stock splits were effected in 2025: a one-for-twenty split on May 6, 2025, and a subsequent one-for-one hundred split on May 22, 2025, both aimed at increasing the per-share price.
• The company is currently in discussions to sell a 51% majority interest in its majority-owned subsidiary, Nobility Healthcare, LLC, expecting an agreement in the near term.

Sentiment

Score: 2

Explanation: The company faces severe financial challenges, including recurring significant losses, a large accumulated deficit, and a 'going concern' warning from both management and auditors. While it has recently raised capital, it explicitly states a need for 'significant additional capital in the near future.' The multiple reverse stock splits and high stock price volatility further indicate distress. The S-1 itself is for resale, not a primary offering, meaning the company doesn't directly benefit from the sale of these specific shares.

Positives

• Secured $750,000 in gross proceeds from the Senior Secured Convertible Note and Warrants agreement on September 15, 2025, with net proceeds of approximately $610,000 used for general corporate purposes and operational expenses.
• Actively pursuing strategic alternatives, including discussions to sell a 51% majority interest in its Nobility Healthcare, LLC subsidiary, which could streamline operations or provide capital.

Negatives

• Incurred operating losses of approximately $15.2 million for the year ended December 31, 2024, and an accumulated deficit of $137.5 million as of December 31, 2024.
• Management and the company's auditor have raised substantial doubt about the company's ability to continue as a going concern due to historical recurring losses and unstable cash flows.
• Reported net losses attributable to common stockholders of $25,688,547 for 2023 and $21,666,691 for 2022.
• The market price for common stock is highly volatile due to its status as a relatively unknown company with a small and thinly traded public float and lack of profits.
• Significant future dilution is possible from the issuance of these registered shares, outstanding options and warrants, and anticipated future equity offerings.
• The company expects significant additional capital will be needed in the near future to continue planned operations, indicating ongoing liquidity challenges.

Risks

• Historical recurring losses from operations and unstable cash flows raise substantial doubt about the ability to continue as a going concern.
• Foreign currency fluctuations may affect competitiveness and sales in foreign markets and could lead to price increases for imported components.
• Revenues and operating results may fluctuate unexpectedly from quarter to quarter, which may cause the stock price to decline.
• Changes in financial accounting standards may cause adverse and unexpected revenue fluctuations and impact reported results of operations.
• Dealing with domestic governmental entities as customers involves budget constraints, political pressures, and potentially long sales cycles.
• Dealing with foreign governmental entities as customers presents similar political and budgetary constraints, long sales cycles, and potential funding issues.
• Failure to stay on top of technology innovation could harm the business model due to rapid technological change, new product introductions, evolving industry standards, and product obsolescence.
• Dependence on key personnel, specifically Stanton E. Ross and Thomas J. Heckman, without key-man life insurance, poses a risk if their services are lost.
• Dependence on a limited number of manufacturers and foreign suppliers for substantially all components and some entire products, leading to risks in availability, delivery schedules, pricing, and product quality.
• Reliance on a single manufacturer (Texas Instruments) for an essential semiconductor chip, with potential for long delays (over six months) and higher costs if supply is interrupted.
• Vulnerability to continued global economic uncertainty and volatility in financial markets, including impacts from the COVID-19 pandemic, global supply chain disruptions, inflation, and economic sanctions.
• The Selling Stockholder may choose to sell the registered shares at prices below the current market price, which could adversely affect the market price of common stock.
• A large number of shares of common stock sold in the market following this offering may significantly depress the market price.
• The market price for common stock is particularly volatile given the company's status as a relatively unknown company with a small and thinly traded public float and lack of profits.
• If securities or industry analysts do not publish research or reports about the business, or publish negative reports, the common stock price and trading volume could decline.
• Potential delisting from the Nasdaq Capital Market could subject shares to 'penny stock' rules, discouraging broker-dealers and severely limiting market liquidity.
• Future dilution may occur as a result of the issuance of these shares, exercise of outstanding stock options/warrants, future equity offerings, and price protection features in existing securities.
• The company could issue blank check preferred stock without stockholder approval, potentially diluting current stockholder interests and impairing voting rights, or discouraging a takeover.
• No intention to pay dividends on shares of common stock for the foreseeable future, requiring investors to rely on price appreciation for gains.
• Economic uncertainties or downturns, or political changes, in the United States and globally, could limit the availability of funds for customers and potential customers.
• Changes in government trade policies, including the imposition of tariffs and export restrictions, could have an adverse impact on business operations and sales.
• Inability to attract, integrate, and retain additional qualified personnel, including top technical talent, could adversely affect the business.
• Potential for litigation for a variety of claims, which could adversely affect results of operations, harm reputation, or otherwise negatively impact the business.
• The requirements of being a U.S. public company may strain resources and divert management's attention, increasing compliance costs and visibility to potential litigation.

Future Outlook

The company expects to reach an agreement in the near term regarding the sale of a 51% majority interest in its Nobility Healthcare, LLC subsidiary. It also anticipates needing to raise significant additional funds in the near future to continue its business plan and service ongoing operations, following the use of proceeds from the November 2024 Private Placement which were expected to cover capital needs for approximately three months. The company also anticipates pursuing the sale of its video solutions business in the short term.

Management Comments

• Our management has concluded that our historical recurring losses from operations and unstable cash flows from operations, as well as our dependence on private equity and other financings, raise substantial doubt about our ability to continue as a going concern.
• Management will strive within the confines of practical limitations to prevent the described patterns [of penny stock fraud and abuse] from being established with respect to our securities.

Industry Context

Digital Ally operates in diverse segments including law enforcement video solutions, healthcare revenue cycle management, and entertainment ticketing/live event production. The video solutions segment faces challenges from governmental budget constraints and rapid technological change. The entertainment segment, through TicketSmarter and live event production, positions the company in the evolving secondary ticketing and event market. The healthcare segment addresses back-office services, a growing area for efficiency. The company's reliance on foreign suppliers and vulnerability to global economic uncertainty and trade policies are common challenges for companies with international supply chains and customer bases.

Corporate Governance

Stakeholder Impact

• Shareholders face significant dilution risk from the current resale offering and potential future equity raises.
• Existing shareholders have experienced substantial dilution and value reduction due to multiple reverse stock splits.
• The 'going concern' warning indicates a high risk of financial instability, potentially impacting all stakeholders.
• Employees and management are critical to the company's success, and their retention is a key risk factor.
• Customers and suppliers may be impacted by the company's financial instability and supply chain risks.
• Creditors are secured by a first priority security interest in most of the company's collateral, except for TicketSmarter, Inc., which grants a second priority security interest.

Next Steps

• The company expects to reach an agreement in the near term to sell a 51% majority interest in its Nobility Healthcare, LLC subsidiary.
• The company anticipates needing to raise significant additional funds in the near future to implement its business plan and service ongoing operations.
• The company anticipates pursuing the sale of its video solutions business in the short term.
• The company will keep the registration statement effective until the securities can be resold without registration or all securities have been sold.

Key Dates

Recommendation

Digital Ally, Inc. presents a highly speculative and distressed investment profile. The company has a history of significant and recurring operating losses, culminating in a substantial accumulated deficit and an explicit 'going concern' warning from both management and its independent auditor. This fundamental financial instability is a critical red flag. The filing itself is for the resale of shares by a selling stockholder, meaning the company receives no direct proceeds from this specific offering, further highlighting a lack of immediate capital injection from this event. While the company has recently raised capital, it explicitly states a need for 'significant additional capital in the near future,' indicating ongoing liquidity challenges. The multiple, aggressive reverse stock splits (1-for-20 followed by 1-for-100 within weeks) are typically signs of a company struggling to maintain its stock price and Nasdaq listing, often leading to further erosion of shareholder value. The stock is characterized by high volatility and a thinly traded public float, making it susceptible to sharp declines. The numerous risks outlined, including dependence on key personnel, supply chain vulnerabilities, and exposure to economic and political factors, compound the negative outlook. Given the severe financial distress, the 'going concern' warning, the history of value destruction through reverse splits, and the explicit need for future capital raises that will likely lead to further dilution, a seasoned investor would likely recommend a 'strong sell' to mitigate further losses.

Keywords

Digital Ally, DGLY, S-1, Registration Statement, Common Stock, Convertible Note, Warrant, Resale, Video Solutions, Revenue Cycle Management, Entertainment Segment, Law Enforcement Technology, Secondary Ticketing, Live Event Production, Going Concern, Reverse Stock Split, Dilution, Capital Raise, SEC Filing